Heramed Limited (HMD) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return

Heramed Limited Chart

Share price
Last
Change
Volume
Turnover
Market Cap $8.97 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

HMD Statistics

18 April

1,728 / 2,323

ASX Size Rank

1yr Return

vs Sector (1yr)

+10.45%

vs ASX 200 (1yr)

+15.43%

$8.97 million

Market Cap

Share Issue

40.75 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

18 April

N/A

PE Ratio

EPS ($)

-

Earnings Yield

-

NTA ($)

-

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

HeraMED Limited (HMD) is a technology startup developing a lineup of innovative connected pregnancy monitoring solutions for home use. Harnessing state-of-the-art technology with superior UX/UI, HeraMED creating solutions that are medically accurate, scientifically optimized, safe and affordable.

Heramed Limited Logo

Corporate Details

Head Office: West Perth
Managing Director: David Groberman
GICS Sub-Industry: Health Care Equipment
Date Listed: 12 Dec 2018
Registry: Automic
Similar Companies: RMD / COH / FPH / ANN / NAN

Upcoming Calendar

27 Feb 2020 Report (Prelim)
27 Mar 2020 Report (Annual)

Dividend History

Ex-Date Amount Franking Type Payable
No dividends paid in the last 5 years

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

HMD is not covered by a major broker.

Directors & Management

About the Data


Name Title Since Bio
Mr David Hinton Non-Executive Director Aug 2018
Dr Ronald (Ron) Peter Weinberger Non-Executive Chairman, Non-Executive Director Aug 2018
Mr Doron Birger Non-Executive Director Oct 2018
Mr David Groberman Chief Executive Officer, Executive Director Sep 2018
Mr Tal Slonim Chief Operating Officer, Executive Director Sep 2018

Director Transactions

About the Data

HMD directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

There are no director transactions for code HMD in our database.

Shareholder Distribution

Shareholder Distribution data is unavailable.

Top 20 Shareholders

About the Data

Name Shares Capital
Altshuler Shaham Trusts Ltd (Holley Pharma Co Ltd A/C) (i) 9,459,901 10.81%
Altshuler Shaham Trusts Ltd (David Groberman A/C) (iii) 7,995,723 9.14%
Altshuler Shaham Trusts Ltd (Tal Slonim A/C) (ii) 7,995,723 9.14%
Altshuler Shaham Trusts Ltd (Exit Valley Investors A/C) (iv) 3,550,421 4.06%
Altshuler Shaham Trusts Ltd (Michael Nenner A/C) (v) 3,040,774 3.47%
Etchell Capital Ltd 3,025,000 3.46%
Chris Ntoumenopoulos 3,025,000 3.46%
Safari Pty Ltd 2,400,000 2.74%
Freeman Road Pty Ltd (The Avenue A/C) 2,400,000 2.74%
J P Morgan Nominees Australia Pty Limited (i) 1,750,000 2.00%
J P Morgan Nominees Australia Limited (ii) 1,400,000 1.60%
Safari Capital Pty Ltd 1,080,000 1.23%
Troca Enterprises Pty Ltd (Coulson Super Fund A/C) 1,055,000 1.21%
The Gas Super Fund Pty Ltd (The Gas Super Fund A/C) (i) 980,000 1.12%
Alta Holdings Pty Ltd (Stillwater A/C) 960,000 1.10%
Mr Phillip John Coulson & Mrs Maria-Luisa Coulson (Coulson Family A/C) 950,000 1.09%
Accbell Nominees Pty Ltd 896,212 1.02%
Mr Kenneth James (James Family A/C) 875,000 1.00%
Altshuler Shaham Trusts Ltd (Mayo Found For Me & R A/C) 734,007 0.84%
The Gas Super Fund Pty Ltd (The Gas Super Fund A/C) (ii) 640,000 0.73%
Citicorp Nominees Pty Limited 600,000 0.69%
Nicole Gallin & Kyle Haynes (GH Super Fund A/C) 560,000 0.64%
Moshe Cohen 550,000 0.63%
All other shareholders 36.08 %


The Top 20 Shareholders of HMD hold 63.92% of shares on issue.

HMD Share Price History

Date Close Change % Change Open High Low Volume Turnover

HMD Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Development, manufacture and distribution of fetal heart beat monitors and other pregnancy-related solutions.

Incorporated: --

Level 2, C/- Nova Legal, 46-50 Kings Park Rd
West Perth WA 6005


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.